Live feed09:23:17·20mANALYSTRatingvia QuantisnowLadenburg Thalmann resumed coverage on Elicio Therapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.ELTX· Elicio Therapeutics Inc.Health CareOriginal source